'Effectively Communicating Your Research' by Nature Research Academies
Funded by SingHealth and Duke-NUS AMC, a workshop on 'Effectively Communicating Your Research' was conducted by the Nature Research Academies on 30 January 2018. The workshop featured trainer Dr Jeffrey Robens, Editorial Development Manager, Nature Research, and PhD from the University of Pennsylvania; and aimed to help researchers in their academic writing by spanning a total of five different writing-related topics and engaging writing activities throughout the day. Read more about the highlights of the workshop here.
Local clinical-stage biotechnology company Tychan
has announced that its first-in-class monoclonal antibody therapeutics for Zika
is now ready for human trials. Developed in a record time of nine months, the
Zika therapeutics was made possible by a technology platform co-founded by Prof
Ooi Eng Eong, Deputy Director, Emerging Infectious Diseases Programme,
Duke-NUS and Co-Director, Viral Research and Experimental Medicine
Centre@SingHealth Duke-NUS (ViREMiCS).